HistoryPedia - Внесок користувача [uk]

N, Mitzner W, Horton MR. A mouse model of chronic idiopathic

2018-02-10T05:36:51Z

Susanbar36:

A mouse model of chronic [http://www.020gz.com/comment/html/?283030.html Oskelet Disord. 2016;17:35. doi:10.1186/s12891-016-0883-4. six. Horkey J, King P.] idiopathic pulmonary fibrosis. Organ L, Bacci B, Koumoundouros E. A novel segmental challenge model for bleomycin-induced pulmonary fibrosis in sheep. Exp Lung Res. 2014;41:115?4. doi:10.3109/01902148.2014.985806. 14. Van der Velden J, Barker D, Barcham G, Koumoundouros E, Snibson K. Improved vascular density is a persistent function of airway remodeling in a sheep model of chronic asthma. Exp Lung Res. 2012;38(six):307?5. doi:10.3109/01902148.2012.697975. 15. Van Der Velden J, Sum G, Barker D, Koumoundouros E, Barcham G, Wulff H, et al. KCa3.1 Channel-Blockade Attenuates Airway Pathophysiology in a Sheep Model of Chronic Asthma. 2008;26(five): 259?6. doi:ten.1016/j.tibtech.2008.02.002. 28. Van der Velden J, Snibson KJ. Airway disease: the usage of big animal models for drug discovery. Pulm Pharmacol Ther. 2011;24(five):525?two. doi:ten.1016/j.pupt.2011.02.001. 29.N, Mitzner W, Horton MR. A mouse model of chronic idiopathic pulmonary fibrosis. Physiol Rep. 2014;two(two):e00249. doi:ten.1002/phy2.249. 13. Organ L, Bacci B, Koumoundouros E. A novel segmental challenge model for bleomycin-induced pulmonary fibrosis in sheep. Exp Lung Res. 2014;41:115?four. doi:10.3109/01902148.2014.985806. 14. Van der Velden J, Barker D, Barcham G, Koumoundouros E, Snibson K. Elevated vascular density can be a persistent function of airway remodeling within a sheep model of chronic asthma. Exp Lung Res. 2012;38(6):307?5. doi:ten.3109/01902148.2012.697975. 15. Van Der Velden J, Sum G, Barker D, Koumoundouros E, Barcham G, Wulff H, et al. KCa3.1 Channel-Blockade Attenuates Airway Pathophysiology within a Sheep Model of Chronic Asthma. PLoS 1. 2013;eight(six):e66886. doi:10.1371/ journal.pone.0066886. 16. Cetti E, Moore A, Geddes D. Collateral ventilation. Thorax. 2006;61(five):371?. doi:10.1136/thx.2006.060509. 17. Tsai LW, Hoffman AM, Mazan MR, Ingenito EP. Bronchoscopic measurement of collateral ventilation inside a sheep model of emphysema. Respiration. 2007;74(5):565?1. doi:10.1159/000103514. 18. Bischof R, Snibson K, Shaw R, Meeusen E. Induction of allergic inflammation within the lungs of sensitized sheep after nearby challenge with home dust mite. Clin Exp Allergy. 2003;33(three):367?5. doi:10.1046/j.13652222.2003.01534.x. 19. Atik A, Sozo [https://dx.doi.org/10.1093/scan/nsx016 title= scan/nsx016] F, Orgeig S, Suri L, Hanita T, Harding R, et al. Long-term pulmonary effects of intrauterine exposure to endotoxin following preterm birth in sheep. Reprod Sci. 2012;19(12):1352?four. doi:10.1177/ 1933719112450327. 20. Maritz G, Probyn M, De Matteo R, Snibson K, Harding R. Lung parenchyma at maturity is influenced by postnatal growth but not by moderate preterm birth in sheep. Neonatology. 2008;93(1):28?5. doi:ten.1159/000105522.21. Samuel CS. Determination of collagen content, concentration, and sub-types in kidney tissue. Kidney Investigation Humana Press; 2009 22. Moodley Y, Vaghjiani V, Chan J, Baltic S, Ryan M, Tchongue J, et al. Anti-inflammatory effects of adult stem cells in sustained lung injury: a comparative study. PLoS One particular. 2013;8(8):e69299. doi:ten.1371/ journal.pone.0069299.

D the bronchoscopy technique for lung function and helped to draft

2018-02-10T04:15:35Z

Susanbar36:

Author specifics 1 Faculty of Veterinary and Agricultural [http://www.medchemexpress.com/Biotin-VAD-FMK.html Biotin-VAD-FMK manufacturer] Science, The University of Melbourne, [http://www.medchemexpress.com/cyclosporin-a.html Cyclosporine chemical information] Parkville, VIC, Australia. Borzone G, Moreno R, Urrea R, Meneses M, Oyarz M, Lisboa C. Bleomycin-induced chronic lung harm will not resemble human idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2001;163(7): 1648?3. doi:ten.1164/ajrccm.163.7.2006132. 9. Moeller A, Ask K, Warburton D, Gauldie J, Kolb M. The bleomycin animal model: a valuable tool to investigate remedy [https://dx.doi.org/10.1089/jir.2011.0103 title= jir.2011.0103] selections for idiopathic pulmonary fibrosis? Int J Biochem Cell Biol. 2008;40(3):362?two. doi:ten.1016/j.biocel.2007.08.011. ten. Scotton C, Hayes B, Alexander R, Datta A, Forty E, Mercer P, et al. Ex vivo CT evaluation of bleomycin-induced lung fibrosis for pre-clinical drug evaluation. Eur Respir J. 2013. doi:10.1183/09031936.00182412. 11. Degryse A, Tanjore H, Xu X, Polosukhin V, Jones B, McMahon F, et al.D the bronchoscopy technique for lung function and helped to draft the manuscript. All authors read and authorized the final manuscript. Acknowledgements We thank Robin Geyer for help with animal management, handling and tissue collection in the end from the animal experiments. None with the authors had distinct funding for this study. C. Samuel is supported by a National Well being Healthcare Investigation Council (NHMRC) of Australia Senior Research Fellowship (APP1041766). Chrishan Samuel is supported by a National Overall health Healthcare Study Council (NHMRC) of Australia Senior Study Fellowship (APP1041766). Author particulars 1 Faculty of Veterinary and Agricultural Science, The University of Melbourne, Parkville, VIC, Australia. 2Faculty of Veterinary and Agricultural Science, The University of Melbourne, Werribee, VIC, Australia. 3Department of Electrical and Electronic Engineering, The University of Melbourne, Parkville, VIC, Australia. 4Department of Pharmacology, Monash University, Clayton, VIC, Australia.Organ et al. BMC Pulmonary Medicine (2015) 15:Page [https://dx.doi.org/10.3389/fnhum.2014.00074 title= fnhum.2014.00074] 14 ofReceived: 8 April 2015 Accepted: 6 JulyReferences 1. Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK, et al. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based recommendations for diagnosis and management. Am J Respir Crit Care Med. 2011;183(six):788?24. doi:10.1164/rccm.2009-040GL. 2. Jr TE, Bradford WZ, Castro-Bernardini S, Fagan EA, Glaspole I, Glassberg MK, et al. A phase three trial of pirfenidone in individuals with idiopathic pulmonary fibrosis. N Engl J Med. 2014;370(22):2083?2. 3. Richeldi L, du RM, Raghu G. Efficacy and security of nintedanib in idiopathic pulmonary fibrosis. .... J Med. 2014;370(22):2071?2. four. Moore B, Lawson W, Oury T, Sisson T, Raghavendran K, Hogaboam C. Animal models of fibrotic lung illness. Am J Respir Cell Mol Biol. 2013;49(two):167?9. doi:10.1165/rcmb.2013-0094TR. five. Chaudhary N, Schnapp A, Park J. Pharmacologic differentiation of inflammation and fibrosis within the rat bleomycin model. Am J Respir Crit Care Med. 2006;173(7):769?6. doi:ten.1164/rccm.200505-717OC. six. Izbicki G, Segel M, Christensen T, Conner M, Breuer R. Time course of bleomycin-induced lung fibrosis. Int J Exp Pathol. 2002;83(3):111?. doi:10.1046/j.1365-2613.2002.00220.x. 7. Peng R, Sridhar S, Tyagi G, Phillips JE, Garrido R, Harris P, et al.

W for 3D reconstruction on the scanned area, which can then

2018-02-03T16:03:37Z

Susanbar36:

Inside the present study, we chose to assess the radiological alterations within the lungs of your sheep that had [http://www.bengals.net/members/markgym40/activity/826425/ W for 3D reconstruction with the scanned area, which can then] showed the worst lung function throughout the study to confirm that injury within the lung occurred inside the segment treated with bleomycin. Additionally, this also enabled us to identify if this tool could possibly be incorporated into our assessment of fibrosis, as has been successfully completed in murine models [10, 32] The scan was performed ex-vivo for practical factors, as it eliminated the need to anesthetize and transport the sheep for the procedure, related to that previously published in a pre-clinical mice model [10]. In CT images, fibrotic lung tissue appeared denser in comparison to regular lungs, which was really clearly visualised on the photos obtained from our sheep lung, showing a clear demarcation of your area locally treated with bleomycin in comparison with the remainder from the lung. This outcome recommended that ex-vivo CT scans could serve as a non-invasive tool for the assessment of fibrotic changesand intervention methods in future research, related to that completed by other people [10, 32].Conclusion In conclusion, the results in the present study demonstrated that a somewhat sustained fibrotic response could be induced into isolated lung segments that also result in a persistent, measurable change in lung compliance. Importantly, the modifications in segmental compliance correlate strongly to pathology; therefore this parameter can serve as a dependable indicator of pathological adjustments within the lung. The assessment of lung function in this model is as a result probably to become a useful predictor in the efficacy of distinctive intervention strategies against pulmonary fibrosis in future preclinical studies. The inclusion of much more clinically relevant endpoints into pre-clinical trials might help in extra accurate identification of potential drug candidates to translate into the clinic.Abbreviations SMA: alpha- Smooth muscle actin; BAL: bronchoalveolar lavage; BLM: bleomycin; Cseg: segmental compliance; ECM: extracellular matrix; HYP: hydroxyproline; IPF: idiopathic pulmonary fibrosis; LC: [https://dx.doi.org/10.1098/rstb.2015.0074 title= rstb.2015.0074] left caudal lobe; RC: correct caudal lobe; SMI: semi-quantitative morphological index; TGF: Transforming development factor. Competing interests The authors declare that they've no competing interest. Authors' contributions LO was the principal researcher for the study, and made the study together with KS. LO performed the lung function analysis, tissue processing for histology, CT scan assessment, histology and immunohistochemistry. LO performed histopathology assessment with BB's help, Masson trichrome staining and collagen evaluation, immunohistochemistry, BAL sampling and cell [http://besocietal.com/members/planet8shrimp/activity/283876/ T of fossils; (3) identification of fossil homologies; (four) sampling work, and (5) fossil] counts. LO also performed the statistical evaluation and drafted the manuscript. BB offered [https://dx.doi.org/10.1089/jir.2011.0103 title= jir.2011.0103] help with establishing the scoring program for assessing the histopathology and subsequent scoring in the tissue and evaluation of histopathology. MM performed the CT scan EK designed the software program plan to assess the lung function and assisted within the lung function evaluation. CS assisted together with the hydroxyproline assay and assessment GB assisted within the sheep trial with animal handling and tissue processing at autopsy. WK assisted in the style from the study and helped draft the manuscript. KS assisted with LO to create the study, and assisted in its style and coordination. KS also performe.W for 3D reconstruction on the scanned location, which can then subsequently be measured and the particular density variety is usually quantified.

D the bronchoscopy method for lung function and helped to draft

2018-02-02T11:06:55Z

Susanbar36:

7. Peng R, Sridhar S, Tyagi G, Phillips JE, Garrido R, Harris P, et al. Bleomycin induces molecular modifications directly relevant to idiopathic pulmonary fibrosis: a model for "active" disease. PLoS A single. 2013;eight(4):e59348. doi:ten.1371/journal.pone.0059348. eight. Borzone G, Moreno R, Urrea R, Meneses M, Oyarz M, Lisboa C.D the bronchoscopy approach for lung function and helped to draft the manuscript. All authors study and approved the final manuscript. Acknowledgements We thank Robin Geyer for assistance with animal management, handling and tissue collection in the finish in the animal experiments. None on the authors had precise funding for this study. C. Samuel is supported by a National Health Health-related Analysis Council (NHMRC) of Australia Senior Study Fellowship (APP1041766). Chrishan Samuel is supported by a National Well being Healthcare Analysis Council (NHMRC) of Australia Senior Research Fellowship (APP1041766). Author details 1 Faculty of Veterinary and Agricultural Science, The University of Melbourne, Parkville, VIC, Australia. 2Faculty of Veterinary and Agricultural Science, The University of Melbourne, Werribee, VIC, Australia. 3Department of Electrical and Electronic Engineering, The University of Melbourne, Parkville, VIC, Australia. 4Department of Pharmacology, Monash University, Clayton, VIC, Australia.Organ et al. Acknowledgements We thank Robin Geyer for assistance with animal management, handling and tissue collection in the end from the animal experiments. None of your authors had specific funding for this study. C. Samuel is supported by a National Health Medical Research Council (NHMRC) of Australia Senior Investigation Fellowship (APP1041766). Chrishan Samuel is supported by a National Wellness Health-related Study Council (NHMRC) of Australia Senior Analysis Fellowship (APP1041766). Author information 1 Faculty of Veterinary and Agricultural Science, The University of Melbourne, Parkville, VIC, Australia. 2Faculty of Veterinary and Agricultural Science, The University of Melbourne, Werribee, VIC, Australia. 3Department of Electrical and Electronic Engineering, The University of Melbourne, Parkville, VIC, Australia. 4Department of Pharmacology, Monash University, Clayton, VIC, Australia.Organ et al. BMC Pulmonary Medicine (2015) 15:Web page [https://dx.doi.org/10.3389/fnhum.2014.00074 title= fnhum.2014.00074] 14 ofReceived: 8 April 2015 Accepted: 6 JulyReferences 1. Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK, et al. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based suggestions for diagnosis and management. Am J Respir Crit Care Med. 2011;183(6):788?24. doi:ten.1164/rccm.2009-040GL. two. Jr TE, Bradford WZ, Castro-Bernardini S, Fagan EA, Glaspole I, Glassberg MK, et al. A phase 3 trial of pirfenidone in sufferers with idiopathic pulmonary fibrosis. N Engl J Med. 2014;370(22):2083?two. 3. Richeldi L, du RM, Raghu G. Efficacy and security of nintedanib in idiopathic pulmonary fibrosis. .... J Med. 2014;370(22):2071?2. 4. Moore B, Lawson W, Oury T, Sisson T, Raghavendran K, Hogaboam C. Animal models of fibrotic lung disease. Am J Respir Cell Mol Biol. 2013;49(two):167?9. doi:10.1165/rcmb.2013-0094TR. five. Chaudhary N, Schnapp A, Park J. Pharmacologic differentiation of inflammation and fibrosis within the rat bleomycin model. Am J Respir Crit Care Med. 2006;173(7):769?6. doi:ten.1164/rccm.200505-717OC. six. Izbicki G, Segel M, Christensen T, Conner M, Breuer R. Time course of bleomycin-induced lung fibrosis. Int J Exp Pathol. doi:10.1152/[http://besocietal.com/members/curvelan8/activity/457609/ . These findings jir.2014.0021 are in consistent with those obtained in preceding reports] ajplung.00026.2010.

N, Mitzner W, Horton MR. A mouse model of chronic idiopathic

2018-02-01T05:39:20Z

Susanbar36:

Samuel CS. Determination of collagen content material, concentration, and sub-types in kidney tissue. Kidney Study Humana Press; 2009 22. Moodley Y, Vaghjiani V, Chan J, Baltic S, Ryan M, Tchongue J, et al. Anti-inflammatory effects of adult stem cells in sustained lung injury: a comparative study. PLoS 1. 2013;8(eight):e69299. doi:10.1371/ journal.pone.0069299. 23. Andoh Y, Shimura S, Aikawa T, Sasaki H, Takishima T. Br J Cancer. 1996;73(1):1560?. 26. Ley B, Collard H, King T. Clinical course and prediction of survival in idiopathic pulmonary fibrosis. 15. Van Der Velden J, Sum G, Barker D, Koumoundouros E, Barcham G, Wulff H, et al. KCa3.1 Channel-Blockade Attenuates Airway Pathophysiology inside a Sheep Model of Chronic Asthma. PLoS One. 2013;8(six):e66886. doi:ten.1371/ journal.pone.0066886. 16. Cetti E, Moore A, Geddes D. doi:10.1159/000103514. 18. Bischof R, Snibson K, Shaw R, Meeusen E. Induction of allergic inflammation in the lungs of sensitized sheep just after regional challenge with property dust mite. Clin Exp Allergy. 2003;33(three):367?5. doi:ten.1046/j.13652222.2003.01534.x. 19. Atik A, Sozo [https://dx.doi.org/10.1093/scan/nsx016 title= scan/nsx016] F, Orgeig S, Suri L, Hanita T, Harding R, et al. Long-term pulmonary effects of intrauterine exposure to endotoxin following preterm birth in sheep. Reprod Sci. 2012;19(12):1352?4. doi:10.1177/ 1933719112450327. 20. Maritz G, Probyn M, De Matteo R, Snibson K, Harding R. Lung parenchyma at maturity is influenced by postnatal growth but not by moderate preterm birth in sheep. Neonatology. 2008;93(1):28?5. doi:ten.1159/000105522.21. Samuel CS. Determination of collagen content, concentration, and sub-types in kidney tissue. Kidney Analysis Humana Press; 2009 22. Moodley Y, Vaghjiani V, Chan J, Baltic S, Ryan M, Tchongue J, et al. Anti-inflammatory effects of adult stem cells in sustained lung injury: a comparative study. PLoS 1. 2013;8(8):e69299. doi:10.1371/ journal.pone.0069299. 23. Andoh Y, Shimura S, Aikawa T, Sasaki H, Takishima T. Perivascular fibrosis of [https://dx.doi.org/10.1098/rstb.2015.0074 title= rstb.2015.0074] muscular pulmonary arteries in chronic obstructive pulmonary disease. CHEST J. 1992;102(6):1645?0. 24. du Bois R, Nathan S, Richeldi L, Schwarz M, Noble P. Idiopathic pulmonary fibrosis: lung function is actually a clinically meaningful endpoint for phase III trials. Am J Respir Crit Care Med. 2012;186(eight):712?. doi:10.1164/rccm.201206-1010PP. 25. Scott HR, McMillan DC, Crilly A, McArdle CS. The relationship involving weight-loss and interleukin 6 in non-small-cell lung cancer. Br J Cancer. 1996;73(1):1560?. 26. Ley B, Collard H, King T. Clinical course and prediction of survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2011;183(four): 431?0. doi:ten.1164/rccm.201006-0894CI. 27. Scheerlinck J-PY, Snibson K, Bowles V, Sutton P. Biomedical applications of sheep models: from asthma to vaccines. Trends Biotechnol. 2008;26(5): 259?six. doi:10.1016/j.tibtech.2008.02.002. 28. Van der Velden J, Snibson KJ. Airway illness: the usage of huge animal models for drug discovery. Pulm Pharmacol Ther. 2011;24(5):525?2. Morphologic-physiologic correlates in the severity of fibrosis and degree of [http://o2b.me/members/jumperman51/activity/451385/ So cause 20 on the general sickness absence recorded within the total] cellularity in idiopathic pulmonary fibrosis.

W for 3D reconstruction in the scanned area, which can then

2018-02-01T04:32:36Z

Susanbar36: Створена сторінка: Inside the current study, we chose to assess the radiological modifications in the lungs of the sheep that had showed the worst lung function all through the st...

Inside the current study, we chose to assess the radiological modifications in the lungs of the sheep that had showed the worst lung function all through the study to confirm that injury inside the lung occurred in the segment treated with bleomycin. Furthermore, this also enabled us to ascertain if this tool might be incorporated into our assessment of fibrosis, as has been effectively carried out in murine models [10, 32] The scan was performed ex-vivo for sensible reasons, as it eliminated the need to [http://www.medchemexpress.com/SCR7.html get SCR7] anesthetize and transport the sheep for the procedure, related to that previously published in a pre-clinical mice model [10]. In CT images, fibrotic lung tissue appeared denser in comparison with regular lungs, which was quite clearly visualised around the pictures obtained from our sheep lung, displaying a clear demarcation of the region locally treated with bleomycin in comparison with the remainder on the lung. This outcome suggested that ex-vivo CT scans could serve as a non-invasive tool for the assessment of fibrotic changesand intervention tactics in future studies, equivalent to that carried out by other people [10, 32].Conclusion In conclusion, the outcomes in the existing study demonstrated that a fairly sustained fibrotic response might be induced into isolated lung segments that also result in a persistent, measurable alter in lung compliance. Importantly, the modifications in segmental compliance correlate strongly to pathology; therefore this parameter can serve as a trusted indicator of pathological changes inside the lung. The assessment of lung function in this model is hence likely to be a helpful predictor from the efficacy of diverse intervention methods against pulmonary fibrosis in future preclinical research. The inclusion of far more clinically relevant endpoints into pre-clinical trials could aid in far more correct identification of potential drug candidates to translate into the clinic.Abbreviations SMA: alpha- Smooth muscle actin; BAL: bronchoalveolar lavage; BLM: bleomycin; Cseg: segmental compliance; ECM: extracellular matrix; HYP: hydroxyproline; IPF: idiopathic pulmonary fibrosis; LC: [https://dx.doi.org/10.1098/rstb.2015.0074 title= rstb.2015.0074] left caudal lobe; RC: suitable caudal lobe; SMI: semi-quantitative morphological index; TGF: Transforming growth aspect. [http://www.medchemexpress.com/AZD0865.html get AZD0865] competing interests The authors declare that they have no competing interest. Authors' contributions LO was the principal researcher for the study, and made the study with each other with KS. LO performed the lung function evaluation, tissue processing for histology, CT scan assessment, histology and immunohistochemistry. LO performed histopathology assessment with BB's assistance, Masson trichrome staining and collagen analysis, immunohistochemistry, BAL sampling and cell counts. LO also performed the statistical evaluation and drafted the manuscript. BB provided [https://dx.doi.org/10.1089/jir.2011.0103 title= jir.2011.0103] assistance with developing the scoring program for assessing the histopathology and subsequent scoring in the tissue and analysis of histopathology. MM performed the CT scan EK designed the computer software plan to assess the lung function and assisted inside the lung function analysis. CS assisted together with the hydroxyproline assay and assessment GB assisted inside the sheep trial with animal handling and tissue processing at autopsy. WK assisted inside the design of the study and helped draft the manuscript. KS assisted with LO to develop the study, and assisted in its design and style and coordination.W for 3D reconstruction of the scanned region, which can then subsequently be measured as well as the specific density variety can be quantified.

W for 3D reconstruction of your scanned region, which can then

2018-01-30T06:38:38Z

Susanbar36:

Additionally, this also enabled us to figure out if this tool could possibly be incorporated into our assessment of fibrosis, as has been effectively completed in murine models [10, 32] The scan was performed ex-vivo for practical reasons, as it eliminated the need to anesthetize and transport the sheep for the procedure, related to that previously [http://support.myyna.com/408096/essor-ashmore-england-university-nottingham-crittenden-and Essor M. Ashmore (England); University of Nottingham, Dr. P. Crittenden and] published within a pre-clinical mice model [10]. BB offered [https://dx.doi.org/10.1089/jir.2011.0103 title= jir.2011.0103] assistance with creating the scoring method for assessing the histopathology and subsequent scoring from the tissue and analysis of histopathology. MM performed the CT scan EK designed the software program to assess the lung function and assisted inside the lung function analysis. CS assisted together with the hydroxyproline assay and assessment GB assisted in the sheep trial with animal handling and tissue processing at autopsy. WK assisted within the style from the study and helped draft the manuscript. KS assisted with LO to create the study, and assisted in its design and coordination.W for 3D reconstruction on the scanned region, which can then subsequently be measured along with the certain density range is often quantified. Inside the present study, we chose to assess the radiological adjustments in the lungs of the sheep that had showed the worst lung function all through the study to confirm that injury inside the lung occurred in the segment treated with bleomycin. Moreover, this also enabled us to determine if this tool could possibly be incorporated into our assessment of fibrosis, as has been successfully carried out in murine models [10, 32] The scan was performed ex-vivo for sensible causes, because it eliminated the must anesthetize and transport the sheep for the process, equivalent to that previously published in a pre-clinical mice model [10]. In CT pictures, fibrotic lung tissue appeared denser compared to normal lungs, which was very clearly visualised on the pictures obtained from our sheep lung, displaying a clear demarcation of the region locally treated with bleomycin in comparison to the remainder in the lung. This result recommended that ex-vivo CT scans could serve as a non-invasive tool for the assessment of fibrotic changesand intervention methods in future research, related to that carried out by others [10, 32].Conclusion In conclusion, the results in the existing study demonstrated that a somewhat sustained fibrotic response may be induced into isolated lung segments that also cause a persistent, measurable modify in lung compliance. Importantly, the modifications in segmental compliance correlate strongly to pathology; for that reason this parameter can serve as a reliable indicator of pathological modifications within the lung. The assessment of lung function within this model is thus probably to become a useful predictor in the efficacy of various intervention strategies against pulmonary fibrosis in future preclinical research. The inclusion of additional clinically relevant endpoints into pre-clinical trials may help in additional accurate identification of potential drug candidates to translate in to the clinic.Abbreviations SMA: alpha- Smooth muscle actin; BAL: bronchoalveolar lavage; BLM: bleomycin; Cseg: segmental compliance; ECM: extracellular matrix; HYP: hydroxyproline; IPF: idiopathic pulmonary fibrosis; LC: [https://dx.doi.org/10.1098/rstb.2015.0074 title= rstb.2015.0074] left caudal lobe; RC: ideal caudal lobe; SMI: semi-quantitative morphological index; TGF: Transforming development aspect. Competing interests The authors declare that they've no competing interest. Authors' contributions LO was the principal researcher for the study, and developed the study together with KS.